Back to search
Cannabinoid Hyperemesis Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabinoid Hyperemesis Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabinoid Hyperemesis Syndrome trials you may qualify forThe aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabi…
Cannabinoid hyperemesis syndrome (CHS) is characterized by incoercible abdominal pain and vomiting in patients with chronic cannabis use. Patients are relieved…
This is an analytical validation observational cohort study is designed to provide evidence of: safety and reliability of Body Surface Gastric Mapping using the…
This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to r…
The purpose of this study is to assess the efficacy of droperidol as a treatment of cannabinoid hyperemesis syndrome.